Literature DB >> 18481072

[Immune reconstitution inflammatory syndrome (IRIS)].

A D Wagner1.   

Abstract

Overwhelming immune reaction resulting in granulomatous inflammation after infection with opportunistic pathogens has been termed immune reconstitution inflammatory syndrome (IRIS). IRIS has mainly been described in patients with human immunodeficiency virus (HIV). However, IRIS is not restricted to HIV-patients and may occur in other infections and immunodeficiencies. In our clinic, we experienced a Whipple's disease patient with IRIS. IRIS occurs mainly after initiation of the highly active anti-retroviral therapy (HAART). Soon after HAART initiation, a marked inflammatory reaction can occur, triggered by restoration of pathogen-specific immunity. IRIS may be targeted by various infective antigens, dead or dying infective antigens, host antigens, tumor antigens and other antigens, giving rise to a heterogenous range of clinical manifestations. Treatment should be optimized for the associated condition and initiated immediately. Glucocorticoids should be used in patients who are severely affected by IRIS.

Entities:  

Mesh:

Year:  2008        PMID: 18481072     DOI: 10.1007/s00393-008-0299-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  53 in total

1.  Graves disease: an increasingly recognized immune reconstitution syndrome.

Authors:  Nancy F Crum; Anuradha Ganesan; Scott T Johns; Mark R Wallace
Journal:  AIDS       Date:  2006-02-14       Impact factor: 4.177

Review 2.  Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease.

Authors:  Leonard H Calabrese; Elizabeth Kirchner; Rabin Shrestha
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

Review 3.  Interactions between HIV infection and leprosy: a paradox.

Authors:  Andrew P Ustianowski; Stephen D Lawn; Diana N J Lockwood
Journal:  Lancet Infect Dis       Date:  2006-06       Impact factor: 25.071

4.  Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy.

Authors:  T Aldeen; P Hay; F Davidson; R Lau
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

Review 5.  Sarcoidosis complicated by HIV infection: three case reports and a review of the literature.

Authors:  W S Lowery; W L Whitlock; R A Dietrich; J M Fine
Journal:  Am Rev Respir Dis       Date:  1990-10

6.  High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.

Authors:  R Manandhar; N Shrestha; C R Butlin; P W Roche
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

7.  An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.

Authors:  Nina Singh; Olivier Lortholary; Barbara D Alexander; Krishan L Gupta; George T John; Kenneth Pursell; Patricia Munoz; Goran B Klintmalm; Valentina Stosor; Ramon del Busto; Ajit P Limaye; Jyoti Somani; Marshall Lyon; Sally Houston; Andrew A House; Timothy L Pruett; Susan Orloff; Atul Humar; Lorraine Dowdy; Julia Garcia-Diaz; Andre C Kalil; Robert A Fisher; Shahid Husain
Journal:  Clin Infect Dis       Date:  2005-04-29       Impact factor: 9.079

Review 8.  Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.

Authors:  R Colebunders; L John; V Huyst; A Kambugu; F Scano; L Lynen
Journal:  Int J Tuberc Lung Dis       Date:  2006-09       Impact factor: 2.373

9.  Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.

Authors:  David M Murdoch; Willem D F Venter; Annelies Van Rie; Charles Feldman
Journal:  AIDS Res Ther       Date:  2007-05-08       Impact factor: 2.250

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.